ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs. Everolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions Julinda Mehilli,
Julinda Mehilli, MD Klinikum der Universitaet Munich Deutsches Herzzentrum Munich Germany
